Metabotropic glutamate receptor (mGluR) (mGluR)

Metabotropic glutamate receptors (mGluRs) are a family of Class C G protein-coupled receptors (GPCRs) that play a fundamental role in modulating synaptic transmission and plasticity throughout the central nervous system (Alexander et al., 2023). Unlike ionotropic glutamate receptors, which function as ligand-gated ion channels, mGluRs exert their effects by activating intracellular signaling cascades via G proteins and second messengers, leading to slower and more sustained physiological responses (Niswender & Conn, 2010). The family is categorized into three groups: Group I (mGluR1, mGluR5) are generally excitatory and coupled to phospholipase C, while Group II (mGluR2, mGluR3) and Group III (mGluR4, mGluR6, mGluR7, mGluR8) typically act as presynaptic autoreceptors that inhibit glutamate release via Gi/o proteins (UniProt Consortium, 2024). These receptors are major therapeutic targets for a wide range of neurological and psychiatric disorders, including schizophrenia, Parkinson's disease, and anxiety, because they allow for the fine-tuning of glutamatergic signaling without the risks of excitotoxicity associated with direct ion channel modulation (StatPearls, 2023). Modern drug discovery focuses heavily on allosteric modulators, which provide superior subtype selectivity and maintain the natural temporal patterns of endogenous signaling.

Other names

mGlu receptorsmGluRsMetabotropic glutamate receptor familyGRMGlutamate receptor metabotropic

Positive allosteric modulation (PAM), negative allosteric modulation (NAM), and orthosteric agonism or antagonism of Class C G protein-coupled receptors to modulate glutamatergic neurotransmission (Niswender & Conn, 2010).